Europe OTC Drug and Dietary Supplement Market
Over the counter (OTC) drugs are available for the public for their general use. These drugs do not require a prescription from a physician. OTC medicines are available for various medical symptoms due to medical conditions such as coughs and colds, diarrhea, heartburn, constipation, acne, pain, and others. On the other hand, dietary supplements are available over the counter for fitness purposes. Whereas, in some cases, when a person is critically ill or requires treatment, then buying a dietary supplement with medicinal ingredients requires a prescription from a physician. These OTC drugs and nutritional supplements have two type, such as branded or generic.
Strategic insights for the Europe OTC Drug and Dietary Supplement provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.
| Report Attribute | Details |
|---|---|
| Market size in 2019 | US$ 85,835.9 Million |
| Market Size by 2027 | US$ 141,676.3 Million |
| Global CAGR (2020 - 2027) | 6.6% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By Product
|
| Regions and Countries Covered | Europe
|
| Market leaders and key company profiles |
The geographic scope of the Europe OTC Drug and Dietary Supplement refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.
The Europe OTC Drug and Dietary Supplement market is expected to reach US$ 141,676.3 million in 2027 from US$ 85,835.9 million in 2019. The market is anticipated to grow with a CAGR of 6.6% from 2020 to 2027. Factors driving the market growth include rising general health issues, and preference of OTC drugs are expected to propel the growth of the market. However, stringent government regulation for OTC drugs is the major factor hindering the market growth. COVID19 has affected the European countries which has led to high number of coronavirus cases. People are buying more immunity booster products as supplement to combat coronavirus effect.
In terms of product, the analgesics segment held the largest share of the market in 2019; however, the vitamins and dietary supplements segment is anticipated to register the highest CAGR in the market during the forecast period. In terms of type, the generic segment held a larger share of the market in 2019 and similar segment is estimated to register a higher market share in the market during the forecast period. Likewise, in terms of form, the in tablets segment held a larger share of the market in 2019 and is estimated to register a higher CAGR in the market during the forecast period. In terms of distribution channel hospital and retail pharmacies held the largest share of market in 2019: however, the online channels segment is anticipated to register the highest CAGR in the market during forecast period.
The World Health Organization (WHO), World Heart Federation, European Pharmacy Network ,National Center for Biotechnology Information are some of the major primary and secondary sources for the Europe OTC Drug and Dietary Supplement market included in the report.
OTC drug and Dietary Supplement– By Product
OTC Drug and Dietary Supplement– By Type
OTC Drug and Dietary Supplement– By Form
OTC Drug and Dietary Supplement – By Distribution Channel
By Country
The List of Companies - Europe OTC Drug and Dietary Supplement Market
The Europe OTC Drug and Dietary Supplement Market is valued at US$ 85,835.9 Million in 2019, it is projected to reach US$ 141,676.3 Million by 2027.
As per our report Europe OTC Drug and Dietary Supplement Market, the market size is valued at US$ 85,835.9 Million in 2019, projecting it to reach US$ 141,676.3 Million by 2027. This translates to a CAGR of approximately 6.6% during the forecast period.
The Europe OTC Drug and Dietary Supplement Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe OTC Drug and Dietary Supplement Market report:
The Europe OTC Drug and Dietary Supplement Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe OTC Drug and Dietary Supplement Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe OTC Drug and Dietary Supplement Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Europe OTC Drug and Dietary Supplement Market
